RecruitingPhase 3NCT06259006
TREAT-SC: Early, Short Course Oral Dexamethasone for the Treatment of Sydenham Chorea in Children
Studying Rheumatic fever
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Starship Child Health, Te Toka Tumai Auckland
- Principal Investigator
- Hannah F Jones, MBChB PhDStarship Child Health, Te Whatu Ora Health New Zealand
- Intervention
- Dexamethasone Oral(drug)
- Enrollment
- 80 enrolled
- Eligibility
- 4-17 years · All sexes
- Timeline
- 2024 – 2028
Study locations (17)
- Royal Darwin Hospital, Darwin, Northern Territories, Australia
- KidzFirst Hospital, Auckland, New Zealand
- Starship Child Health, Te Toka Tumai, Auckland, Auckland, New Zealand
- Waitākere Hospital, Auckland, New Zealand
- Gisborne Hospital, Gisborne, New Zealand
- Waikato Hospital, Hamilton, New Zealand
- Hawkes Bay Fallen Soldiers' Memorial Hospital, Hastings, New Zealand
- Hutt Hospital, Lower Hutt, New Zealand
- Wairarapa Hospital, Masterton, New Zealand
- Taranaki Base Hospital, New Plymouth, New Zealand
- Palmerston North Hospital, Palmerston North, New Zealand
- Rotorua Hospital, Rotorua, New Zealand
- Tauranga Hospital, Tauranga, New Zealand
- Wellington Regional Hospital, Wellington, New Zealand
- Whakatāne Hospital, Whakatāne, New Zealand
- +2 more locations on ClinicalTrials.gov
Collaborators
Health Research Council, New Zealand · Menzies School of Health Research
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06259006 on ClinicalTrials.govOther trials for Rheumatic fever
Additional recruiting or active studies for the same condition.